Skip to content

PLSE

Pulse Biosciences, Inc.

NASDAQ · USHealthcareMedical - Instruments & Supplies
$28.96+0.98%

Price as of Jul 20, 2026

PLSE capital

Pulse Biosciences, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.11x
Net debt / equity
-0.92x
Debt / assets
0.09x
Debt / EBITDA
-0.10x
Net debt / EBITDA
0.83x

Liquidity & coverage

Current ratio
7.26x
Quick ratio
7.24x
Cash ratio
6.97x
Interest coverage
EBITDA / interest
Working capital
$61.3M

Cash & dividend

FCF / debt
-7.76x
Cash flow / debt
-7.71x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.